Nothing Special   »   [go: up one dir, main page]

FI20116008A0 - Viskeraalisen rasvan estäminen ja diagnostisointi - Google Patents

Viskeraalisen rasvan estäminen ja diagnostisointi

Info

Publication number
FI20116008A0
FI20116008A0 FI20116008A FI20116008A FI20116008A0 FI 20116008 A0 FI20116008 A0 FI 20116008A0 FI 20116008 A FI20116008 A FI 20116008A FI 20116008 A FI20116008 A FI 20116008A FI 20116008 A0 FI20116008 A0 FI 20116008A0
Authority
FI
Finland
Prior art keywords
visceral fat
bifidobacteria
diagnosis
prevention
relates
Prior art date
Application number
FI20116008A
Other languages
English (en)
Swedish (sv)
Original Assignee
Maeyrae Maekinen Annika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maeyrae Maekinen Annika filed Critical Maeyrae Maekinen Annika
Priority to FI20116008A priority Critical patent/FI20116008A0/fi
Publication of FI20116008A0 publication Critical patent/FI20116008A0/fi
Priority to ES12839611.6T priority patent/ES2660396T3/es
Priority to PCT/FI2012/050979 priority patent/WO2013054002A1/en
Priority to US14/350,957 priority patent/US10000818B2/en
Priority to EP12839611.6A priority patent/EP2766026B1/en
Priority to DK12839611.6T priority patent/DK2766026T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4869Determining body composition
    • A61B5/4872Body fat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
FI20116008A 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi FI20116008A0 (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi
ES12839611.6T ES2660396T3 (es) 2011-10-12 2012-10-12 Prevención y diagnosis de grasa visceral
PCT/FI2012/050979 WO2013054002A1 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat
US14/350,957 US10000818B2 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat
EP12839611.6A EP2766026B1 (en) 2011-10-12 2012-10-12 Prevention and diagnosis of visceral fat
DK12839611.6T DK2766026T3 (en) 2011-10-12 2012-10-12 PREVENTION AND DIAGNOSIS OF VISCERAL FAT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi

Publications (1)

Publication Number Publication Date
FI20116008A0 true FI20116008A0 (fi) 2011-10-12

Family

ID=44883676

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20116008A FI20116008A0 (fi) 2011-10-12 2011-10-12 Viskeraalisen rasvan estäminen ja diagnostisointi

Country Status (6)

Country Link
US (1) US10000818B2 (fi)
EP (1) EP2766026B1 (fi)
DK (1) DK2766026T3 (fi)
ES (1) ES2660396T3 (fi)
FI (1) FI20116008A0 (fi)
WO (1) WO2013054002A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104780932A (zh) 2012-02-29 2015-07-15 伊西康内外科公司 微生物区系的组合物及与其相关的方法
WO2015013214A2 (en) 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment
FI127483B (fi) * 2014-06-11 2018-07-13 Gut Guide Oy Mikrobiomarkkeri keliakialle ja siihen liittyvä tuote
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105586293B (zh) * 2015-12-30 2018-09-25 四川剑南春(集团)有限责任公司 一种新的乳酸利用梭菌及其用途
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP3645025B1 (en) 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing atherosclerosis
EP4159224A1 (en) * 2017-06-30 2023-04-05 N.V. Nutricia Synbiotic composition for preventing chronic inflammation
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US20210238659A1 (en) * 2017-11-02 2021-08-05 Gc Corporation Intraoral examination method using information on bacterial group related to clinical indexes
CN113403375A (zh) * 2021-02-20 2021-09-17 北京金则医学检验实验室有限公司 一种用于预测儿童肥胖症的组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI112504B (fi) 2002-08-07 2003-12-15 Cyflo Oy Menetelmä bakteerien tunnistamiseksi
BRPI0607743B1 (pt) 2005-02-28 2020-09-15 N. V. Nutricia Composição nutricional prebiótica para bebês e uso de uma composição nutricional prebiótica para bebês
EP2102350A4 (en) * 2006-12-18 2012-08-08 Univ St Louis INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER
DE102006062250A1 (de) * 2006-12-22 2008-06-26 Roland Saur-Brosch Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
JPWO2008081834A1 (ja) 2006-12-28 2010-04-30 江崎グリコ株式会社 グリコーゲンを含む食品とその用途
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
CA2707656C (en) * 2007-12-06 2018-05-22 Arla Foods Amba Probiotic bacteria and regulation of fat storage
WO2011005756A1 (en) * 2009-07-06 2011-01-13 Puretech Ventures, Llc Delivery of agents targeted to microbiota niches
WO2011013106A1 (en) * 2009-07-30 2011-02-03 Danisco A/S Lactic acid bacteria and bifidobacteria for treating endotoxemia
US20120149584A1 (en) * 2009-08-21 2012-06-14 Bernat Olle Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
EP2308499A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
US20160281142A1 (en) * 2015-03-25 2016-09-29 Nestec Sa Methods for predicting overweight risk for pets and adult percent body fat

Also Published As

Publication number Publication date
US10000818B2 (en) 2018-06-19
EP2766026A1 (en) 2014-08-20
DK2766026T3 (en) 2018-03-05
WO2013054002A1 (en) 2013-04-18
EP2766026B1 (en) 2017-11-29
EP2766026A4 (en) 2015-05-06
ES2660396T3 (es) 2018-03-22
US20140286920A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
FI20116008A0 (fi) Viskeraalisen rasvan estäminen ja diagnostisointi
FI20116007A0 (fi) Serotoniinitason nostaminen ja diagnostisointi
EA201792547A1 (ru) Популяции бактерий для стимуляции состояния здоровья
PH12015501291B1 (en) Functionalized exendin-4 derivatives
WO2014169226A3 (en) Methods of diagnosing and treating chronic pain
AU2019268177A1 (en) Improving resistance to skeletal muscle fatigue
UA112068C2 (uk) Гелева композиція
PH12020500164A1 (en) Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
PH12016500475B1 (en) Food composition
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
CY1113661T1 (el) Προϊον τυριου εναλλακτικου τυπου και μεθοδος παραγωγης του ιδιου
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
WO2011080396A3 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status
MX2015012548A (es) Metodos para estimular la maduracion de pulmones e intestinos infantiles.
MX342832B (es) Tratamiento o prevencion de una infeccion.
MX2018000189A (es) Metodo para el diagnostico de la enfermedad de farber.
EA201291440A1 (ru) Пробиотические штаммы для применения при повышении трансэпителиального сопротивления
MY171693A (en) Method for manufacturing low-protein rice and food using low-protein rice
IN2012DN06393A (fi)
IN2014MN01760A (fi)
MX2012003931A (es) Metodos para identificar animales con capacidad reducida para digerir lipidos y proteinas.
BR112018009381A2 (pt) suplemento alimentar compreendendo beta-glucano e hidrolisado de caseína para melhora da saúde e desempenho de crescimento em um mamífero
NZ762407A (en) Novel lactic acid bacteria and use thereof
Miguel et al. Objective and subjective methods for estimation of carcass conformation and degree of fatness as predictors of meat sensory quality of Rubia de El Molar ovine breed.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: GUT GUIDE OY

FD Application lapsed